Berger disease: Thirty years later

European Journal of Pediatrics

Volumn 158, Issue 6, 1999, Pages 437-443

  Davin, J C ^b   Weening, J J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ACE I; IgA CC; IgAN; Mesangial cells

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OMEGA 3 FATTY ACID;

ANAPHYLACTOID PURPURA; ASTHENIA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FEVER; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MALAISE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; PROGNOSIS;

EID: 0033008569     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051115     Document Type: Review

References (87)

1. 1. Andreoli SP, Bergstein JM (1989) Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248-252
2. 2. Allen AC, Harper SJ, Feehally J (1995) Galactosylation of N-and O-linked carbohydrate moities of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100:470-474
3. 3. Bannister KM, Weaver A, Clarkson AR, Woodroffe AJ (1995) Effect of angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy. In: Clarkson AR, Woodroffe AJ (eds) IgA nephropathy: pathogenesis and treatment. Contrib Nephrol 111:184-193
4. 4. Batsford SR, Weghaupt R, Takamiya H, Vogt A (1985) Studies on the mesangial handling of protein antigens: influence of size, charge and biologic activity. Nephron 41:146-151
5. 5. Berger J (1984) IgA mesangial nephropathy 1968-1983. Contrib Nephrol 40:4-6
6. 6. Berger J, Hinglais N (1968) Les dépôts intercapillaires d'IgA-IgG. J Urol Nephrol 74:694-695
7. 7. Broyer M (1983) Fréquence et cause de l'insuffisance rénale chez l'enfant. In: Royer P, Habib R, Matthieu H, Broyer M (eds) Néphrologie Pédiatrique. Flammarion Médecine-Sciences, Paris, pp 425-433
8. 8. Casanueva B, Rodriguez-Valverde V, Farinas MC, Vallo A, Rodriguez-Soriano J (1990) Autologous mixed lymphocyte reaction and T-cell suppressor activity in patients with Henoch-Schönlein purpura and IgA nephropathy. Nephron 54:224-228
9. 9. Cattran DC, Greenwood C, Ritchie S (1994) Long-term benefits of angiotensin-converting enzyme inhibitor treatment with other anti-hypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23:247-254
10. 10. Cederholm B, Wieslander J, Bygren P, Heinegard D (1988) Ciculating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 5: 4865-4868
11. 11. Clarkson AR (1987) IgA nephropathy: history, classification and geographic distribution. In: Clarkson AR (ed) IgA nephropathy. Martinus Nijhoff Publishing, Boston, pp 1-8
12. 12. Clarkson AR (1987) Clinical and laboratory features of IgA nephropathy. In: Clarkson AR (ed) IgA nephropathy, Martinus Nijhoff Publishing. Boston, p 9-15
13. 13. Clarkson AR (1987) The treatment of IgA nephropathy. In: Clarkson AR (ed) IgA nephropathy, Martinus Nijhoff Publishing, Boston, pp 214-227
14. 14. Coppo R, Basolo B, Piccoli G (1984) IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol 57:583-590
15. 15. Cortes P, Riser B, Narins RG (1996) Glomerular hypertension and progressive renal disease: the interplay of mesangial cell stretch, cytokines formation and extracellular matrix synthesis. Contrib Nephrol 118:229-233
16. 16. Czerkinsky C, Koopman WJ, Jackson S (1986) Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 77:1931-1938
17. 17. D'Amico G (1983) Idiopathic mesangial nephropathy. In: Bertani T, Remuzzi G (eds) Glomerular injury 300 years after Morgani. Milan Wichting Editore, pp 205-228
18. 18. D'Amico G (1984) Natural history and treatment of idiopathic IgA nephropathy. In: Robinson RR (ed) Nephrology. Springer, Berlin Heidelberg New York, pp 686-699
19. 19. D'Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 245:709-727
20. 20. Davies M (1994) The mesangial cell: a tissue culture view. Kidney Int 45:320-327
21. 21. Davin JC (1993) Contribution à l'étude de la pathogénie des néphropathies à IgA. Thèse d'Aggrègation, Université de Liège
22. 22. Davin JC, Vandenbroeck MC, Foidart JB, Mahieu PR (1985) Sequential measurements of the reticulo-endothelial system function in Henoch-Schönlein disease in childhood. Correlation with various immunological parameters. Acta Paediatr Scand 74:201-206
23. 23. Davin JC, Foidart JB, Mahieu PR (1987) Relation between bioligical IgA abnormalities and mesangial IgA deposits in isolated hematuria of childhood. Clin Nephrol 28:73-80
24. 24. Davin JC, Forget P, Mahieu PR (1988) Increased intestinal permeability to (51 Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies. Acta Paediatr Scand 77:118-124
25. 25. Davin JC, Dechenne C, Lombet J, Rentier B, Foidart JB, Mahieu PR (1989) Acute experimental glomerulonephrities induced by the glomerular deposition of circulating polymeric IgA-concanavalin A complexes. Virchows Archiv A Pathol Anat Histopathol 415:7-20
26. 26. Davin JC, Li Vecchi M, Nagy J, Foidart JM, Foidart JB, Barbagallo Sangiorgi G, Malaise M, Mahieu P (1991) Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in IgA nephropathy. J Clin Immunol 11:78-94
27. 27. Delacroix DL (1985) The human immunogloglobulin A system. Its vascular compartment. Thesis. European Medical Press, Brugge
28. 28. Demaine AG, Rambausek M, Knight JF, William DG, Welsh KI, Ritz E (1988) Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region. J Clin Invest 81:611-614
29. 29. Donadio JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE (1994) A controlled trial of fish oil in IgA nephropathy. NEJM 331:1194-1198
30. 30. Droz D, Noël LH (1983) Ré-évaluation du pronostic des glomérulonéphrites à dépôts intercapillaires d'IgA. Semin Nephrol Pediatr 26-31
31. 31. Druet P, Bariety J, Bernard D, Lagrue G (1970) Les glomérulonéphrites primitives à dépôts mésangiaux d'IgA et d'IgG. Etude clinique et morphologique de 52 cas. Press Med 78:583-587
32. 32. Egido J, Sancho J, Mampaso F, Lopez-Trascana M, Sanchez-Crespo M, Blasco R, Hernando L (1980) A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schönlein-Henoch syndrome. Proc Eur Dial Transplant Assoc 17:660-666
33. 33. Egido J, Julian B, Wyatt RJ (1987) Genetic factors in IgA nephropathy. Nephrol Dial Transplant 2:134-142
34. 34. Emancipator SN (1990) Immunoregulatory factors in the pathogenesis of IgA nephropathy. Kidney Int 38:1216-1229
35. 35. Emancipator SN (1993) Primary and secondary forms of IgA nephritis and Schönlein-Henoch syndrome. In: Heptinstall RH (ed) Pathology of the Kidney. Little, Brown, Toronto, pp 389-476
36. 36. Emancipator SN (1994) IgA nephropathy: morphologic expression and pathogenesis. Am J Kidney Dis 23:451-462
37. 37. Faille-Kuyper EH, Kater L, Kuitjen RH, Kooiker CJ Wagenaar SS, Zouwen P van der, Mees EJ (1976) Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease. Kidney Int 9:424-429
38. 38. Fijter JW de, Eijgeraam JW, Braam CA, Holmgren J, Daha MR, Es LA van, Wall Bake AW van der (1996) Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 50:952-961
39. 39. Gesualdo L, Pinzani M, Floriano JJ, Hassan MO, Nagy NU, Schena FP, Emancipator SN, Abboud HE (1991) Platelet derived growth factor expression in mesangial proliferative glomerulonephrities. Lab Invest 65:160-167
40. 40. Gommez-Guerrero C, Gonzalez E, Egido J (1993) Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 151:7172-7181
41. 41. Habib R (1983) Purpura rhumato. In: Royer P, Habib R, Matthieu H, Broyer M (eds) Néphrologie pédiatrique. Flammarion Médecine et Sciences, Paris, pp 342-350
42. 42. Hartung R, Livingstone B, Excell L, Disney A, Woodroffe AJ (1995) Recurrence of IgA deposits/disease in grafts. An Australian registry survey 1980-1990. In: Clarkson AR, Woodroffe AJ (eds) IgA nephropathy: pathogenesis and treatment. Karger, Basel, Contrib Nephrol 11:13-17
43. 43. Hogg RG, Silva FG (1987) IgA nephropathy in children. In: Clarkson AR (ed) IgA nephropathy. Martinus Nijhoff Publishing, Boston, pp 16-38
44. 44. Horii Y, Muraguchi A, Iwano M, Matsuda T, Hiramaya T, Yamada H, Fuji Y, Dohi K, Ishikawa H, Ohmotto Y, Yoshizaki K, Hirano T, Kishimoto T (1989) Involvement of I1-6 in mesangial proliferative glomerulonephritis. J Immunol 143:3949-3955
45. 45. Jones CL, Powell HR, Kincaid-Smith P, Roberton DM (1990) Polymeric IgA and immune complex concentrations in IgA-related renal disease. Kidney Int 38:323-331
46. 46. Julian BA, Barker C (1993) Alternate-day prednisone therapy in IgA nephropathy. Contrib Nephrol 104:198-206
47. 47. Kobayashi Y, Fujii K, Hiki Y, Tateno S (1986) Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases. Q J Med 61:935-938
48. 48. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S (1996) Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron 72:237-242
49. 49. Kokubo T, Hiki Y, Iwase H, Horii A, Tanaka A, Nishikido J, Hotta K, Kobayashi Y (1997) Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 8:915-919
50. 50. Lagrue G, Sadreux T, Laurent J, Hirbec G (1980) Is there a treatment for IgA glomerulonephritis. Clin Nephrol 26:174-180
51. 51. Lai K, Lai FM, HO CP, Chan KW (1986) Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Cline Nephrol 26:174-186
52. 52. Lai KN, Chui SH, Lai FM, Lam CW (1988) Predominent synthesis of IgA with lambda light chain in IgA nephropathy. Kidney Int 33:584-589
53. 53. Lai KN, Leung JC, Li PK, Lui SF (1991) Cytokine production by peripheral blood mononuclear cells in IgA nephropathy. Clin Exp Immunol 85:240-245
54. 54. Levy M, Moussa RA, Habib R, Gagnadoux MF, Broyer M (1982) Anaphylactoid purpura nephritis and transplantation. Kidney Int 22:326-327
55. 55. Levy M, Gonzalez-Burchard G, Maladie de Bergen (1983) In: Royer P, Habib, Mathieu H, Broyer M (eds) Néphrologie pédiatrique. Flammarion Médecine-Sciences, Paris, pp 329-341
56. 56. Levy M, Gonzales-Burchard G, Broyer M, Domergues JP, Foulard M, Sorez JP, Habib R (1985) Berger's disease in children. Natural history and outcome. Medicine 64:157-180
57. 57. Libetta C, Rampino T, Palumbo G, Esposito C, Dal Canton A (1997) Circulating serum leclins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells. J Am Soc Nephrol 8:208-203
58. 58. Martini A, Magrini U, Scelsi M, Capelli V, Barberis L (1981) Chronic mesangioproliferative IgA glomerulonephritis complicated by a rapidly progressive course in a 14-year-old boy. A case reporl. Nephron 29:164-166
59. 59. Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, Sasdelli M, Zuccala A, Zuchelli P (1994) Ace inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transpl 9:225-269
60. 60. Meadow SR, Scott DG (1985) Berger disease: Henoch-Schölein without the rash. J Pediatr 106:27-32
61. 61. Michael AF, Fish AJ, Good RA (1967) Glomerular localization and transport of aggregated proteins in mice. Lab Invest 17:14-29
62. 62. Monteiro RC, Albwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P (1985) Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666-671
63. 63. Montinaro V, Hevey K, Aventaggiato L, Fadden, K, Esparza A, Chen A, Finbloom DS Rifai A (1992) Extrarenal cylokines modulate the glomerular response to IgA immune complexes. Kidney Int 42:341-353
64. 64. Mustonen J, Pasternak A(1987) Associated diseases in IgA nephropathy. In: Clarkson AR (ed) IgA nephropathy. Martinus Nijhoff Publishing, Boston, pp 47-65
65. 65. Nicholls KM, Kincaid-Smith P (1984) Defective in vivo Fc and C3b receptor function in IgA nephropathy. Am J Kidney Dis 4: 128-134
66. 66. Noble NA, Border WA (1997) Angiotensine II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol 17:455-466
67. 67. Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Cillis D, Thomas AC, Matthew TH, Woodroffe AJ (1994) Reccurent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9:309-312
68. 68. Power DA, Muirhead N, Simpson JG, Nicholls AJ, Horne CH, Catto GR, Edward N (1985) IgA nephropathy is not a rare disease in the United Kindom. Nephron 40:180-184
69. 69. Ravelli A, Carnevale-Maffe G, Ruperto N, Ascari E, Martini A (1996) IgA nephropathy and Henoch-Schonlein syndrome occurring in the same patient. Nephron 72:111-112
70. 70. Rekola S, Bergstrand A, Bucht H (1991) Deterioration rate in IgA nephropathy: comparison of a converting enzyme inhibitor and beta-blocking agents. Nephron 59:57-60
71. 71. Rifai A, Small PA, Teague PO, Ayoub EM (1979) Experimental IgA nephropathy. J Exp Med 150:1161-1173
72. 72. Rifai A, Schena FP, Montinaro V, Mele M, D'Addabbo A, Nitti L, Pezzullo JC (1989) Clearance kinetics and fate of macromolecular IgA in patients IgA nephropathy. Lab Invest 61:381-388
73. 73. Rodicio JL (1984) Idiopathic IgA nephropathy. Kidney Int 25:717-719
74. 74. Rostoker R, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L, Terzidis H, Intrator L, André C, Adnot S, Bonin P, Bierling P, Remy P, Lagrue G, Lang P, Weil B (1995) Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Nephron 69:327-334
75. 75. Sakai H, Nomoto Y, Tomino Y, Endoh M, Miura M, Suga T (1987) Increase of in vivo and in vitro production of polycolonal IgA in patients and their family members with IgA nephropathy. Adv Exp Med Biol 216B:1507-1514
76. 76. Sakai H. Miyazaki M, Endoh M, Nomoto Y (1989) Increase of IgA-Specific switch T cells in patients with IgA nephropathy. Clin Exp Immunol 78:378-382
77. 77. Schena FP (1992) IgA nephropathies. In: Camernon S, Davison AM, Grünfeld JP, Ken D, Ritz E (eds) Oxford textbook of clinical nephrology. Oxford Univeristy Press, pp 339-369
78. 78. Schena FP, Mastrolitti G, Jirillo E, Munno, Pellegrino N, Fracasso AR, Aventaggiato L (1989) Increase production of interleukin-2 and Il-2 receptor in primary IgA nephropathy. Kidney Int 35:875-879
79. 79. Schena FP, Pastore A, Ludovico N, Sinico RA, Benuzzi S, Montinaro V (1989) Increased levels of IgA1-IgG immune complexes and anti F(ab')2 antibodies in patients with primary IgA nephropathy. Clin Exp Immunol 77:15-20
80. 80. Schlöndorff D, De Candido S, Satriano JA (1990) Angiotensine II stimulates stimulates phospholipases C and A2. Am J Physiol 258:F927-F933
81. 81. Scivittaro V, Amore A, Emancipator SN (1993) Animal models as a mean to study IgA nephropathy. Contrib Nephrol 104:65-78
82. 82. Silva FG, Chander P, Pirani CL, Hardy MA (1982) Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33:241-246
83. 83. Sinniah R (1987) The pathology of IgA nephropathy. In: Clarkson AR (ed) IgA nephropathy. Martinus Nijhoff Publishing, Boston, pp 66-96
84. 84. Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG (1982) IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA 79:6229-6231
85. 85. Tomino Y, Endoh M, Nomoto Y, Sakai H (1981) Immunoglobulin A1 and IgA nephropathy. N Engl J Med 305:1159-1160
86. 86. Welch TR, Berry A, Beischl LS (1987) C4 isotype deficiency in IgA nephropathy. Pediatr Nephrol 1:136-139
87. 87. Yoshikawa N, Ito H, Nakamura H (1989) IgAN in children from Japan. Child Nephrol Urol 9:191-199